Suchergebnisse - "PD-1"

PubPharm (2.510)

1

Hepatic arterial infusion chemotherapy, lenvatinib plus programmed cell death protein-1 inhibitors : A promising treatment approach for high-burden hepatocellular carcinoma

enthalten in: Cancer medicine | 2024

von Fu, S. | Xu, Y. | Mao, Y. | +6

2

Comprehensive multi-omics analysis of resectable locally advanced gastric cancer : Assessing response to neoadjuvant camrelizumab and chemotherapy in a single-center, open-label, single-arm phase II trial

enthalten in: Clinical and translational medicine | 2024

von Zhao, Y. | Li, D. | Zhuang, J. | +23

3

TP53 disruptive mutation predicts platinum-based chemotherapy and PD-1/PD-L1 blockade response in urothelial carcinoma

enthalten in: The Journal of pathology | 2024

von Jin, K. | Xu, J. | Su, X. | +12

4

GNUV201, a novel human/mouse cross-reactive and low pH-selective anti-PD-1 monoclonal antibody for cancer immunotherapy

enthalten in: BMC immunology | 2024

von Kim, H. | Kim, K. | Lee, K. | +13

5

Autologous patient-derived exhausted nano T-cells exploit tumor immune evasion to engage an effective cancer therapy

enthalten in: Molecular cancer | 2024

von Blaya-Cánovas, J. | Griñán-Lisón, C. | Blancas, I. | +18

6

Deep learning based digital pathology for predicting treatment response to first-line PD-1 blockade in advanced gastric cancer

enthalten in: Journal of translational medicine | 2024

von Liu, Y. | Chen, W. | Ruan, R. | +8

7

PD-1 : A critical player and target for immune normalization

enthalten in: Immunology | 2024

von Liu, X. | Zhao, A. | Xiao, S. | +4

8

T-reg transcriptomic signatures identify response to check-point inhibitors

enthalten in: Scientific reports | 2024

von Noblejas-López, M. | García-Gil, E. | Pérez-Segura, P. | +3

9

PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6high uterine leiomyosarcoma to PD-1 blockade

enthalten in: Clinical and translational medicine | 2024

von De Wispelaere, W. | Annibali, D. | Tuyaerts, S. | +24

10

Impact of Increasing PD-L1 Levels on Outcomes to PD-1/PD-L1 Inhibition in Patients With NSCLC : A Pooled Analysis of 11 Prospective Clinical Trials

enthalten in: The oncologist | 2024

von Vallejo, J. | Singh, H. | Larkins, E. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[251]